Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study. (2023)

First Author: Yusuf IH
Attributed to:  Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41433-023-02399-x

PubMed Identifier: 37085718

Publication URI: http://europepmc.org/abstract/MED/37085718

Type: Journal Article/Review

Parent Publication: Eye (London, England)

ISSN: 0950-222X